Skip to main content
. 2016 Aug 29;10:149–155. doi: 10.4137/CMC.S32804

Table 2.

The effects of Clopidogrel and Prasugrel on hs-CRP over 12 weeks study period.

CLOPIDOGREL GROUP (n = 80) PRASUGREL GROUP (n =40) CLOPIDOGREL VERSUS PRASUGREL (WITHIN SUBGROUPS)
HS-CRP BEFORE TREATMENT (mg/dl) P VALUE (BETWEEN SUBGROUPS) HS-CRP AFTER TREATMENT (mg/dl) PERCENT OF CHANGE (%) P VALUE (BETWEEN SUBGROUPS) HS-CRP BEFORETREATMENT (mg/dl) P VALUE (BETWEEN |SUBGROUPS) HS-CRP AFTER TREATMENT (mg/dl) PERCENT OF CHANGE (%) P VALUE (BETWEEN SUBGROUPS) P VALUE
All 15.10
(9.62–23.75)
8.50
(6.00–10.75)
39.33
(15.71–62.55)
18.00
(14.25–22.00)
5.00
(3.00–5.00)
72.95
(61.53–85.33)
0.002
Gender Male 11.25
(8.37–19.75)
0.03 8.00
(4.00–10.00)
48.68
(21.61–62.55)
0.18 18.00
(15.00–22.00)
0.92 5
(3.00–5.00)
73.68
(64.10–84.96)
0.74 <0.001
Female 18.00
(11.25–28.75)
10.00
(6.00–20.00)
33.33
(6.07–62.34)
18.00
(12.00–23.00)
5.00
(3.00–9.00)
68.75
(59.09–86.36)
<0.001
DM Yes 15.00
(9.50–21.00)
0.91 11.00
(6.00–20.00)
25.00
(4.76–33.33)
0.007 15.00
(12.00–22.00)
0.08 5
(3.00–5.00)
66.66
(59.09–83.33)
0.14 <0.001
No 15.20
(9.25–24.25)
8.00
(4.75–10.00)
50.00
(21.17–64.39)
19.00
(15.75–22.50)
5.00
(3.00–5.00)
73.68
(66.88–86.03)
<0.001
HTN Yes 17.50
(11.50–24.00)
0.01 10.00
(8.00–13.00)
33.33
(20–60)
0.77 15.50
(12.50–22.00)
0.06 5.00
(3.00–5.00)
67.85
(60.31–82.08)
0.07 <0.001
No 10.46
(6.90–23.00)
6.00
(4.00–9.50)
48.68
(14.28–63.40)
19.00
(18.00–23.00)
5.00
(3.00–5.00)
83.33
(67.10–86.95)
<0.001
Current smoking Yes 15.00
(9.87–25.75)
0.72 9.00
(60–11.50)
33.33
(9.58–64.39)
0.40 18.00
(15.00–22.00)
0.82 4.50
(3.00–5.00)
74.34
(66.66–86.36)
0.38 <0.001
No 15.20
(8.00–23.00)
8.00
(4.00–10.00)
47.36
(25.00–58.33)
19.00
(13.00–22.00)
5.00
(3.00–5.00)
70.03
(59.53–83.99)
<0.001
Beta blocker Yes 10.20
(5.00–17.00)
<0.001 6.00
(2.00–11.00)
25.00
(4.76–50.00)
<0.001 18.00
(12.50–22.00)
0.65 5.00
(3.00–5.00)
75
(61.20–83.77)
0.90 <0.001
No 19.00
(11.35–30.25)
9.00
(6.00–12.00)
55.31
(26.43–65.33)
18.00
(15.00–22.00)
5.00
(3.00–5.00)
72.22
(61.53–86.36)
<0.001
ACEI/ARB Yes 8.75
(5.00–15.00)
<0.001 6.00
(2.00–10.00)
30.55
(13.04–56.52)
0.02 18.00
(15.00–22.00)
0.79 4.00
(3.00–5.00)
78.57
(66.66–85.71)
0.68 <0.001
No 19.00
(12.00–25.00)
9.75
(8.00–11.00)
50.00
(21.73–64.70)
19.00
(12.00–22.00)
5.00
(3.00–5.00)
72.22
(61.20–84.84)
<0.001
CCB Yes 9.25
(4.92–17.75)
0.01 7.00
(3.00–10.00)
32.63
(16.14–57.88)
0.51 15.00
(12.00–22.00)
0.08 5.00
(3.00–6.00)
66.66
(60.42–76.83)
0.04 <0.001
No 17.40
(10.05–25.00)
9.25
(6.00–16.25)
45.58
(14.78–64.60)
19.00
(15.42–22.00)
4.50
(3.00–5.00)
77.92
(66.66–86.51)
<0.001
Index event Elective 8
(4.97–17.00)
<0.001 6.00
(2.75–6.75)
25.00
(9.58–61.17)
0.11 16.25
(13.5–21.75)
0.01 3.50
(3.00–5.00)
78.40
(66.66–86.64)
0.65 <0.001
UA 15.10
(10.20–24.00)
8.50
(8.00–10.00)
44.27
(21.56–58.33)
17
(12.00–21.50)
5.00
(3.00–5.00)
75.47
(59.13–85.60)
<0.001
NSTEMI 25.00
(21.00–49.50)
18.00
(10.00–20.00
33.33
(24.26–63.22)
22
(19.00–27.00)
5.00
(3.00–9.00)
72.22
(59.09–86.36)
0.01
STEMI 28.50
(22.00–42.50)
10.00
(9.62–18.25)
59.80
(51.32–66.50)
22.00
(14.60–25.50)
9.00
(4.00–9.00)
67.10
(59.98–73.21)
0.01
Index procedure One-vessel 19.00
(10.20–28.00
0.04 9.00
(6.00–10.00)
64.28
(21.56–83.33)
0.01 16.50
(13.75–22.00)
0.36 5.00
(3.75–5.00)
72.95
(65.38–79.38)
0.60 0.12
Multi-vessel 15.00
(6.97–23.25)
8.00
(5.75–14.25)
33.33
(13.04–56.52)
18.5
(14.65–22.25)
4.00
(3.00–6.00)
73.61
(60.42–86.36)
<0.001
Stent POBA 19.00
(9.50–29.00)
0.06 9.50
(3.00–10.00)
67.24
(28–83.33)
0.03 16.00
(12.00–22.00)
0.46 3.00
(2.00–5.00)
83.33
(58.33–87.50)
0.30 0.07
DES 13.50
(8.50–19.75)
8.00
(5.25–12.50)
35.41
(13.35–56.52)
18.00
(13.50–22.00)
5.00
(3.25–5.00)
67.48
(61.53–80.68)
<0.001
BMS 28.00
(9.85–40.50)
10.00
(8.25–12.50)
41.17
(10.69–69.04)
19.00
(15.25–22.00)
3.00
(3.00–5.00)
78.57
(62.87–86.73)
0.004

Note: Data are shown as numbers (percentage).

Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMS, bare metal stent; CCB, Calcium channel blocker; DES, drug-eluting stent; DM, diabetes mellitus; HTN, hypertension; NSTEMI, non-ST segment elevation myocardial infarction; POBA, plain old balloon angioplasty; STEMI, ST segment elevation myocardial infarction; UA, unstable angina.